🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carl W. Baker

ORCID: 0000-0003-4048-9923

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)”.

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Ophthalmology(2020)10.1016/j.ophtha.2020.03.021

N/A

7.1DataRank · unranked

199 citations

John A. Wells, Kristin Josic, Maureen G. Maguire, Andrew N. Antoszyk, Carl W. Baker +5 more

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema

New England Journal of Medicine(2022)10.1056/nejmoa2204225

N/A

3.0DataRank · unranked

86 citations

Adam R. Glassman, Frederick L. Ferris, Danni Liu, Maureen G. Maguire, John B. Allen +11 more

A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)

Ophthalmology Retina(2021)10.1016/j.oret.2021.10.003

N/A

0.550DataRank · unranked

38 citations

Adam R. Glassman, Kristin Josic, Michele Melia, Lloyd Paul Aiello, Carl W. Baker +10 more

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity

JAMA Ophthalmology(2020)10.1001/jamaophthalmol.2019.6035

N/A

0DataRank · unranked

48 citations

Carl W. Baker, Wesley T. Beaulieu, Neil M. Bressler, Omar S. Punjabi, Cynthia R. Stockdale +5 more